A 58-year-old patient with a history of type 2 diabetes mellitus presents with symptoms of peripheral neuropathy, retinopathy, and early nephropathy. The patient's HbA1c is 9.2%, indicating poor glycemic control. Which of the following interventions should the nurse prioritize to address the patient's current complications and prevent further progression?

B) Discuss the potential benefits of initiating a GLP-1 receptor agonist with the healthcare provider.

A) Educate the patient about the importance of a low sodium diet to manage blood pressure.

B) Discuss the potential benefits of initiating a GLP-1 receptor agonist with the healthcare provider.

C) Advise the patient to increase fluid intake to prevent dehydration.

D) Recommend the use of over-the-counter pain medications for neuropathic pain.

A 58-year-old female with a history of type 2 diabetes mellitus presents with symptoms suggestive of peripheral neuropathy and retinopathy, along with laboratory findings indicating diabetic nephropathy. Which nursing intervention is most appropriate to address the patient's current complications and prevent further progression?

A) Encourage the patient to perform daily foot inspections and wear appropriate footwear.

B) Advise the patient to increase protein intake to support kidney function.

C) Recommend over-the-counter eye drops to alleviate blurred vision.

D) Suggest the patient reduce fluid intake to manage elevated creatinine levels.

A patient with type 2 diabetes has been prescribed a GLP-1 receptor agonist and an SGLT2 inhibitor due to inadequate glycemic control and early-stage diabetic nephropathy. In addition to medication, which nursing intervention is most important to address the patient's risk of foot complications?

B) Instruct the patient to perform daily foot inspections for signs of injury or infection.

A) Educate the patient on the importance of daily blood glucose monitoring.

B) Instruct the patient to perform daily foot inspections for signs of injury or infection.

C) Schedule monthly appointments for a complete blood count (CBC) to monitor for anemia.

D) Recommend an increase in physical activity to improve circulation in the lower extremities.

A patient with type 2 diabetes mellitus is experiencing improved glycemic control after the addition of a GLP-1 receptor agonist, but reports new-onset tingling and burning sensations in the feet. Which nursing intervention is most appropriate to address the patient's neuropathic symptoms and prevent further complications?

B) Educate the patient on daily foot care routines, including inspection and moisturizing, to prevent foot injuries.

A) Increase the frequency of blood glucose monitoring to maintain optimal glycemic levels.

B) Educate the patient on daily foot care routines, including inspection and moisturizing, to prevent foot injuries.

C) Suggest an increase in physical activity to enhance circulation and reduce neuropathic pain.

D) Recommend the patient to apply warm compresses to the feet to alleviate tingling sensations.

A patient with type 2 diabetes is being treated with an SGLT2 inhibitor and a GLP-1 receptor agonist. She reports increased urination and thirst, and her serum creatinine has risen. Which nursing intervention is most appropriate to address these symptoms while ensuring continued renal protection?

A) Educate the patient on increasing fluid intake to prevent dehydration.

B) Instruct the patient to decrease the dose of the SGLT2 inhibitor.

C) Advise the patient to monitor blood glucose levels more frequently.

D) Recommend the patient stop the GLP-1 receptor agonist to reduce polyuria.

A patient with type 2 diabetes mellitus is on an SGLT2 inhibitor and a GLP-1 receptor agonist. She reports increased urination and thirst, and recent lab work shows a slight increase in serum creatinine and urine albumin-to-creatinine ratio. Which nursing intervention should be prioritized to address the patient's current condition and medication side effects?

B) Discuss dietary modifications to reduce sodium intake and support renal function.

A) Encourage the patient to increase her water intake to compensate for fluid loss.

B) Discuss dietary modifications to reduce sodium intake and support renal function.

C) Educate the patient on the importance of continuing antihypertensive medication to maintain blood pressure control.

D) Schedule weekly follow-up appointments to monitor blood glucose levels more closely.

A 68-year-old female with a history of hypertension and diabetes mellitus is experiencing increased fatigue and dizziness, particularly when standing. Her standing blood pressure is 110/70 mmHg, and her serum creatinine has risen to 1.6 mg/dL. Which nursing intervention should be prioritized to address her symptoms of orthostatic hypotension while considering her renal impairment?

B) Advise the patient to change positions slowly to reduce dizziness.

A) Encourage the patient to increase her sodium intake to improve blood pressure.

B) Advise the patient to change positions slowly to reduce dizziness.

C) Increase the patient's diuretic dose to manage potential fluid overload.

D) Recommend reducing fluid intake to prevent further renal impairment.

A patient with a history of hypertension and type 2 diabetes is experiencing fatigue and dizziness upon standing. Her recent lab results show increased serum creatinine and urine albumin-to-creatinine ratio. Which nursing intervention is most appropriate to address her symptoms and prevent further renal compromise?

B) Advise the patient to increase fluid intake and monitor blood pressure regularly.

A) Encourage the patient to reduce antihypertensive medication to prevent orthostatic hypotension.

B) Advise the patient to increase fluid intake and monitor blood pressure regularly.

C) Recommend discontinuing the SGLT2 inhibitor to improve renal function.

D) Suggest the patient increase dietary sodium to enhance fluid retention.

A patient with a history of diabetic nephropathy presents with bilateral pitting edema, orthostatic hypotension, and increased serum creatinine levels. The healthcare team has reduced the dose of the patient's SGLT2 inhibitor and is considering introducing a non-steroidal mineralocorticoid receptor antagonist. Which nursing intervention is most appropriate to prioritize for this patient?

A) Educate the patient on the importance of daily weight monitoring to assess fluid retention.

B) Instruct the patient to increase fluid intake to manage orthostatic hypotension.

C) Advise the patient to reduce sodium intake to manage edema.

D) Encourage the patient to engage in regular physical activity to improve circulation.

A patient with a history of diabetes and recent renal impairment presents with persistent fatigue, lower extremity swelling, and orthostatic hypotension. Recent lab results indicate increased BUN and serum creatinine levels, along with a higher urine albumin-to-creatinine ratio. The healthcare team decides to modify the patient's medication regimen by reducing the dose of an SGLT2 inhibitor. What is the primary reason for adjusting the SGLT2 inhibitor dose in this patient?

B) To reduce the risk of volume depletion and worsening orthostatic hypotension

A) To enhance glucose control in response to increased renal impairment

B) To reduce the risk of volume depletion and worsening orthostatic hypotension

C) To prevent further increase in blood pressure due to fluid retention

D) To increase the effectiveness of the non-steroidal mineralocorticoid receptor antagonist

diabetes mellitus - Nursing Case Study

Pathophysiology

• Primary mechanism: Diabetes mellitus is characterized by impaired insulin action and/or secretion. In Type 1 diabetes, autoimmune destruction of pancreatic beta cells leads to insufficient insulin production. In Type 2 diabetes, insulin resistance in peripheral tissues, often due to obesity or genetic factors, results in inadequate glucose uptake despite normal or high insulin levels.

• Secondary mechanism: Chronic high blood glucose levels (hyperglycemia) occur due to reduced insulin effectiveness. This triggers increased glucose production by the liver and impaired glucose uptake by muscle and adipose tissues, exacerbating hyperglycemia.

• Key complication: Persistent hyperglycemia causes damage to blood vessels and nerves, leading to complications such as neuropathy, nephropathy, and retinopathy, which are significant causes of morbidity in diabetic patients.

Patient Profile

Demographics:

58-year-old female, office manager

History:

• Key past medical history: Type 2 diabetes mellitus diagnosed 8 years ago, hypertension, hyperlipidemia

• Current medications: Metformin 1000 mg twice daily, Lisinopril 20 mg daily, Atorvastatin 20 mg daily, Aspirin 81 mg daily

• Allergies: Penicillin

Current Presentation:

• Chief complaint: Increasing fatigue and intermittent blurred vision

• Key symptoms: Polyuria, polydipsia, occasional tingling in feet, recent weight loss

• Vital signs: Blood pressure 150/95 mmHg, heart rate 88 bpm, respiratory rate 18 breaths per minute, temperature 98.6°F, blood glucose 220 mg/dL

Section 1

As the healthcare team proceeds with the initial assessment, they note several concerning findings that suggest the development of diabetic complications. During the physical examination, the patient reports an increase in the tingling sensation in her feet, which has now progressed to occasional numbness, particularly at night. This suggests the onset of peripheral neuropathy, a common complication of longstanding diabetes mellitus. Additionally, the patient exhibits signs of retinopathy; fundoscopic examination reveals microaneurysms and cotton wool spots, indicating damage to the tiny blood vessels in the eyes. This correlates with her complaint of intermittent blurred vision, a symptom often associated with retinal changes due to chronic hyperglycemia.

Laboratory results further support the presence of complications. The patient's HbA1c level is measured at 9.2%, indicating poor long-term glucose control and confirming the persistence of hyperglycemia. Serum creatinine is slightly elevated at 1.4 mg/dL, with an estimated glomerular filtration rate (eGFR) of 55 mL/min/1.73m², suggesting early-stage diabetic nephropathy. Urinalysis reveals microalbuminuria, which is consistent with early kidney damage. These findings underscore the importance of addressing her uncontrolled diabetes to prevent further progression of these complications.

These assessment findings necessitate a comprehensive approach to management, focusing on optimizing glycemic control and monitoring for potential worsening of complications. The healthcare team considers adjustments in her medication regimen, possibly adding a glucagon-like peptide-1 (GLP-1) receptor agonist or a sodium-glucose cotransporter-2 (SGLT2) inhibitor to improve her blood glucose levels and provide cardiovascular and renal protection. Close follow-up with an ophthalmologist for retinal assessment and a nephrologist for kidney function monitoring is also warranted. These steps are crucial in altering the course of her diabetes management and mitigating the risk of further complications.

Section 2

Two weeks after the initial assessment, the patient returns for a follow-up visit. The healthcare team notes a slight improvement in her glycemic control, as her daily blood glucose logs show a decrease in fasting glucose levels from an average of 180 mg/dL to 140 mg/dL. This change follows the addition of a GLP-1 receptor agonist to her regimen, along with dietary modifications. However, the patient reports persistent tingling and numbness in her feet, which are now accompanied by occasional sharp, burning sensations. These symptoms suggest the progression of peripheral neuropathy, necessitating further evaluation and management to prevent potential complications such as foot ulcers.

During this visit, the team conducts a comprehensive foot examination, revealing decreased sensation in both feet, particularly in the distal areas. The monofilament test confirms diminished protective sensation, raising concerns about the patient's risk for foot injuries and ulcerations. The team emphasizes the importance of daily foot care and regular podiatry consultations, alongside further adjustments to her medication regimen to better manage her neuropathic symptoms.

To address the early-stage diabetic nephropathy suggested by previous findings, the patient's treatment plan includes the initiation of an SGLT2 inhibitor. This medication is expected to provide renal protection and aid in further lowering her HbA1c. The team schedules a consultation with a nephrologist to establish a baseline and develop a tailored plan for ongoing kidney function monitoring. These coordinated efforts aim to stabilize her condition and prevent the advancement of diabetic complications, underscoring the importance of comprehensive and proactive diabetes management.

Section 3

Two months after the initiation of the SGLT2 inhibitor and with continued use of the GLP-1 receptor agonist, the patient returns for another follow-up visit. During this appointment, the healthcare team observes that her fasting blood glucose levels have further improved, now averaging 120 mg/dL. Her HbA1c has decreased from 8.5% to 7.4%, indicating better overall glycemic control. However, the patient reports experiencing increased frequency of urination and a sensation of thirst, prompting the team to review her medication regimen and adjust her dietary and fluid intake to mitigate these side effects.

New diagnostic results from recent lab work reveal a slight increase in her serum creatinine levels, now at 1.4 mg/dL compared to the previous 1.2 mg/dL, suggesting the need for closer monitoring of her renal function. The urine albumin-to-creatinine ratio has also shown a mild increase, reinforcing the importance of the nephrology consultation and the continued use of the SGLT2 inhibitor for renal protection. The patient's blood pressure remains well-controlled at 130/80 mmHg, and she is advised to maintain her current antihypertensive medication regimen.

In addition to the ongoing management of her diabetes and renal health, the patient reports significant relief in her neuropathic symptoms following the introduction of a low-dose tricyclic antidepressant prescribed at her last visit. This improvement has positively impacted her quality of life, allowing her to engage more actively in daily activities and adhere to an exercise routine. The healthcare team continues to emphasize the importance of foot care and regular podiatry visits to ensure early detection and treatment of any potential foot complications. This holistic approach aims to sustain the patient's progress and prevent further complications, integrating clinical reasoning and patient education into her care plan.

Section 4

Two months later, the patient returns for another follow-up appointment. During this visit, she reports an increase in fatigue and occasional dizziness, particularly when standing up quickly. The healthcare team conducts a thorough assessment and notes that her blood pressure upon standing is 110/70 mmHg, indicating a possible case of orthostatic hypotension. This finding prompts the team to review her antihypertensive regimen and consider potential interactions with her current diabetes medications, particularly the SGLT2 inhibitor, which can contribute to volume depletion.

Recent lab results reveal that her serum creatinine has increased further to 1.6 mg/dL, raising concerns about her renal function. The urine albumin-to-creatinine ratio has also increased slightly, which, combined with her current symptoms, suggests that her renal health requires more focused attention. A nephrology consultation is prioritized to evaluate the progression of her renal impairment and discuss possible adjustments to her medication regimen to balance glycemic control with renal protection.

In response to her symptoms and lab findings, the healthcare team advises the patient to increase her fluid intake cautiously and monitor her blood pressure regularly at home. They emphasize the importance of managing her fluid status to prevent further renal compromise while maintaining effective blood pressure control. The team also discusses the potential need to adjust her medication doses or explore alternative treatments if renal function continues to decline. This comprehensive approach not only aims to address her immediate symptoms but also to prevent further complications, ensuring that her overall health and quality of life are maintained.

Section 5

Two weeks later, the patient returns for another follow-up appointment, reporting persistent fatigue and a new onset of swelling in her lower extremities. Upon examination, the healthcare team notes bilateral pitting edema around her ankles and a slight increase in weight, which may indicate fluid retention. Her blood pressure is measured at 130/85 mmHg while seated, but drops to 105/65 mmHg when she stands, confirming worsening orthostatic hypotension. Given her current symptoms and the recent history of renal impairment, the team suspects that her renal function may be declining further, potentially exacerbated by her current medication regimen.

Further diagnostic testing reveals a slight increase in her blood urea nitrogen (BUN) to 28 mg/dL, and her serum creatinine has risen to 1.8 mg/dL. Additionally, her urine albumin-to-creatinine ratio shows a more substantial increase, suggesting a progression in diabetic nephropathy. These findings, combined with her symptoms of edema and orthostatic hypotension, prompt the healthcare team to consider modifying her treatment plan. They decide to reduce the dose of her SGLT2 inhibitor to alleviate the potential for volume depletion and discuss the possibility of introducing a non-steroidal mineralocorticoid receptor antagonist to provide renal protection while managing her blood pressure.

In response to these developments, the healthcare team emphasizes the importance of closely monitoring her symptoms and blood pressure at home, advising her to report any further changes immediately. They also stress the need for regular follow-up appointments to assess her renal function and adjust her treatment as necessary. This proactive approach aims to stabilize her condition, prevent further complications, and optimize her treatment plan to preserve renal function while effectively managing her diabetes and hypertension.